Clinical Intervention

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 51-60 of 109 total displayed.

Past content

Research Article
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial

Nancy L. Cho, Mark Redston, Ann G. Zauber, Adelaide M. Carothers, Jason Hornick, Andrew Wilton, Stephen Sontag, Norman Nishioka, Francis M. Giardiello, John R. Saltzman, Chris Gostout, Craig J. Eagle, Ernest T. Hawk, and Monica M. Bertagnolli
Cancer Prevention Research first published on Apr 14, 2008 as doi: 10.1158/1940-6207.CAPR-07-0011. [Abstract] Online First [PDF]  

Research Articles: Therapeutics, Targets, and Development
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes

Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, and Clinton J. Grubbs
Mol. Cancer Ther. 2008; 7: 972-979. [Abstract] [Full text] [PDF]  

Null Results in Brief
The Ratio of Specific Polychlorinated Biphenyls as a Surrogate Biomarker of Cytochrome P4501A2 Activity—A Pharmaco-Metabonomic Study in Humans

Xibiao Ye, Edward F. Fitzgerald, Marta I. Gomez, George H. Lambert, and Matthew P. Longnecker
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1013-1015. [Full text] [PDF]  

Cancer Therapy: Clinical
Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions

Vassiliki A. Papadimitrakopoulou, William N. William, Jr., Andrew J. Dannenberg, Scott M. Lippman, J. Jack Lee, Frank G. Ondrey, Douglas E. Peterson, Lei Feng, Anthea Atwell, Adel K. El-Naggar, Cherie-Ann Nathan, Joseph I. Helman, Baoheng Du, Bevan Yueh, and Jay O. Boyle
Clin. Cancer Res. 2008; 14: 2095-2101. [Abstract] [Full text] [PDF]  

Research Article
Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells

Jie Zhang, Kentaro Iwanaga, Kuicheon C. Choi, Marie Wislez, Maria Gabriela Raso, Wei Wei, Ignacio I. Wistuba, and Jonathan M. Kurie
Cancer Prevention Research first published on Mar 31, 2008 as doi: 10.1158/1940-6207.CAPR-08-0014. [Abstract] Online First [PDF]  

Research Articles
Urinary 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine in Patients with Parasite Infection and Effect of Antiparasitic Drug in Relation to Cholangiocarcinogenesis

Raynoo Thanan, Mariko Murata, Somchai Pinlaor, Paiboon Sithithaworn, Narong Khuntikeo, Walaluk Tangkanakul, Yusuke Hiraku, Shinji Oikawa, Puangrat Yongvanit, and Shosuke Kawanishi
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 518-524. [Abstract] [Full text] [PDF]  

Research Articles
Decreased Expression of UK114 Is Related to the Differentiation Status of Human Hepatocellular Carcinoma

Chin-Liew Chong, Shiu-Feng Huang, Cheng-po Hu, Ya-Ling Chen, Hsin-Ying Chou, Gar-Yang Chau, Jin-Yuh Shew, Yue-Lin Tsai, Chiung-Tong Chen, Chungming Chang, and Mong-Liang Chen
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 535-542. [Abstract] [Full text] [PDF]  

Research Articles
Progestin Treatment Induces Apoptosis and Modulates Transforming Growth Factor-β in the Uterine Endometrium

Gustavo C. Rodriguez, B.J. Rimel, William Watkin, Jane M. Turbov, Cathy Barry, Hongyan Du, George L. Maxwell, and J.M. Cline
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 578-584. [Abstract] [Full text] [PDF]  

Research Articles
Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

Joel M. Reid, Sumithra J. Mandrekar, Elsa C. Carlson, W. Scott Harmsen, Erin M. Green, Renee M. McGovern, Eva Szabo, Matthew M. Ames, Daniel Boring, Paul J. Limburg for the Cancer Prevention Network
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 674-679. [Abstract] [Full text] [PDF]  

Research Articles
The Effect of Difluoromethylornithine on Decreasing Prostate Size and Polyamines in Men: Results of a Year-Long Phase IIb Randomized Placebo-Controlled Chemoprevention Trial

Anne R. Simoneau, Eugene W. Gerner, Ray Nagle, Argyrios Ziogas, Sharon Fujikawa-Brooks, Hagit Yerushalmi, Thomas E. Ahlering, Ronald Lieberman, Christine E. McLaren, Hoda Anton-Culver, and Frank L. Meyskens, Jr.
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 292-299. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11